About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Monthly Archives: September 2007
Congress is back. They take up more room inside the Beltway. That means traffic, among other things. School is in. More traffic. We are all back in the saddle again. The heat of summer seems to have gotten the hint … Continue reading
As the Medicare Part D experience completed its first year, there have been a number of opinions expressed on how well the benefit did what it set out to do – provide seniors with a benefit on prescription drug access. … Continue reading
Congress is back from recess. Quite a lively recess it was too, if you read the papers. As tempting as it is to weigh in on that, I’ll go on to other matters. First of all, SCHIP – the State … Continue reading
We are all trying to re-enter the workforce after August. Here in the Beltway, the Congress is headed back and the traffic congestion returns as students everywhere return to school. Labor Day Weekend has passed and alas, I have put … Continue reading